Evaluation of tumor ischemia in response to an indole-based vascular disrupting agent using BLI and (19)F MRI.
about
The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts.Developing oxygen-enhanced magnetic resonance imaging as a prognostic biomarker of radiation response.Synthesis and Biological Evaluation of Benzocyclooctene-based and Indene-based Anticancer Agents that Function as Inhibitors of Tubulin Polymerization.The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells.
P2860
Evaluation of tumor ischemia in response to an indole-based vascular disrupting agent using BLI and (19)F MRI.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Evaluation of tumor ischemia i ...... agent using BLI and (19)F MRI.
@ast
Evaluation of tumor ischemia i ...... agent using BLI and (19)F MRI.
@en
type
label
Evaluation of tumor ischemia i ...... agent using BLI and (19)F MRI.
@ast
Evaluation of tumor ischemia i ...... agent using BLI and (19)F MRI.
@en
prefLabel
Evaluation of tumor ischemia i ...... agent using BLI and (19)F MRI.
@ast
Evaluation of tumor ischemia i ...... agent using BLI and (19)F MRI.
@en
P2093
P2860
P1476
Evaluation of tumor ischemia i ...... agent using BLI and (19)F MRI.
@en
P2093
Edward E Graves
Heling Zhou
Kevin G Pinney
Mary Lynn Trawick
Matthew T MacDonough
Ralph P Mason
Rami R Hallac
Ramona Lopez
P2860
P304
P577
2015-01-15T00:00:00Z